Li Han, Zhang Ke, Chen Wei, Zhou Yuxuan, Li Jun, Zhao Yunfang, Song Yuelin
Modern Research Center for Traditional Chinese Medicine, Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Chin Med. 2024 Apr 26;19(1):64. doi: 10.1186/s13020-024-00931-z.
As one of the most famous natural products, salvianolic acid A (SAA) is undergoing clinical trials for the treatments of angina pectoris and coronary heart disorders. However, the in vivo metabolites of SAA have only been tentatively identified, leading to a barrier for precise therapeutical drug monitoring.
Ultra-high performance liquid chromatography coupled with quadrupole time of flight tandem mass spectrometry (UPLC-Qtof-MS/MS) was firstly employed to acquire high-resolution MS and MS spectra for all metabolites. Through paying special attention onto the features of ester bond dissociation, metabolism sites were restricted at certain regions. To further determine the metabolism site, such as the monomethylated products (M23, M25, and M26), post collision-induced dissociation energy-resolved mass spectrometry (post-CID ER-MS) was proposed through programming progressive exciting energies to the second collision chamber of hybrid triple quadrupole-linear ion trap mass spectrometry (Qtrap-MS) device.
After SAA oral administration, 29 metabolites (M1-M29), including five, thirteen, and sixteen ones in rat plasma, urine, and feces, respectively, were detected in rats. The metabolism route was initially determined by applying well-defined mass fragmentation pathways to those HR-m/z values of precursor and fragment ions. Metabolism site was limited to SAF- or DSS-unit based on the fragmentation patterns of ester functional group. Through matching the dissociation trajectories of concerned 1-generation fragment ions with expected decomposition product anions using post-CID ER-MS strategy, M23 and M25 were unequivocally assigned as 3'-methyl-SAA and 3''-methyl-SAA, and M26 was identified as 2-methyl-SAA or 3-methyl-SAA. Hydrolysis, methylation, glucuronidation, sulfation, and oxidation were the primary metabolism channels being responsible for the metabolites' generation.
Together, the metabolism regions and sites of SAA metabolites were sequentially identified based on the ester bond dissociation features and post-CID ER-MS strategy. Importantly, the present study provided a promising way to elevate the structural identification confidence of natural products and metabolites.
作为最著名的天然产物之一,丹酚酸A(SAA)正在进行治疗心绞痛和冠心病的临床试验。然而,SAA的体内代谢产物仅得到初步鉴定,这为精确的治疗药物监测带来了障碍。
首先采用超高效液相色谱-四极杆飞行时间串联质谱联用技术(UPLC-Qtof-MS/MS)获取所有代谢产物的高分辨率质谱和二级质谱。通过特别关注酯键断裂的特征,将代谢位点限定在特定区域。为进一步确定代谢位点,如单甲基化产物(M23、M25和M26),通过对混合型三重四极杆-线性离子阱质谱仪(Qtrap-MS)的第二个碰撞室设置渐进的激发能量,提出了碰撞诱导解离能量分辨质谱法(post-CID ER-MS)。
大鼠口服SAA后,在大鼠血浆、尿液和粪便中分别检测到29种代谢产物(M1-M29),其中血浆中有5种,尿液中有13种,粪便中有16种。通过将明确的质量碎裂途径应用于前体离子和碎片离子的高分辨m/z值,初步确定了代谢途径。根据酯官能团的碎裂模式,代谢位点局限于SAF-或DSS-单元。通过使用post-CID ER-MS策略将相关一代碎片离子的解离轨迹与预期的分解产物阴离子进行匹配,明确将M23和M25鉴定为3'-甲基-SAA和3''-甲基-SAA,M26鉴定为2-甲基-SAA或3-甲基-SAA。水解、甲基化、葡萄糖醛酸化、硫酸化和氧化是产生这些代谢产物的主要代谢途径。
基于酯键断裂特征和post-CID ER-MS策略,依次鉴定了SAA代谢产物的代谢区域和位点。重要的是,本研究为提高天然产物及其代谢产物的结构鉴定可信度提供了一种有前景的方法。